Internal Medicine NewsFDA OKs first ustekinumab biosimilarNovember 1, 2023Rare DiseasesMusculoskeletal DisordersGastroenterologyDermatologyRheumatology
Internal Medicine NewsMale patients with breast cancer: Special considerations and gender-specific concernsOctober 13, 2023Breast CancerRare DiseasesOncologyMen's Health
Internal Medicine NewsGuillain-Barré syndrome: Honing treatment strategiesOctober 13, 2023Rare DiseasesImmunologyNeurology
Internal Medicine News3-D stereophotogrammetry helps detect progression of craniofacial morpheaOctober 12, 2023DermatologyRare Diseases
Internal Medicine NewsAnti-acid meds lower strength of systemic sclerosis drugOctober 11, 2023RheumatologyGastroenterologyRare Diseases
Internal Medicine NewsFDA approves first tocilizumab biosimilarOctober 3, 2023RheumatologyRare DiseasesMusculoskeletal DisordersImmunology
Internal Medicine NewsInterstitial lung disease plus pulmonary hypertension equals poor outcomes in systemic sclerosisAugust 29, 2023PulmonologyRare Diseases
Internal Medicine NewsMohs found to confer survival benefit in localized Merkel cell carcinomaAugust 24, 2023DermatologyOncologyRare Diseases
Internal Medicine NewsFDA okays first-ever new drug for rare bone disorderAugust 17, 2023Rare DiseasesEndocrinology
Internal Medicine NewsA 75-year-old White woman presented with diffuse erythema, scale, and pruritus on her scalpAugust 16, 2023Rare DiseasesDermatology
Internal Medicine NewsWest Nile infections rising in the U.S.August 15, 2023Infectious DiseasesNeurologyRare Diseases
Internal Medicine NewsAutoantibody against enteric nervous system protein linked to GI dysfunction in systemic sclerosisAugust 8, 2023DermatologyGastroenterologyRheumatologyRare Diseases
Internal Medicine NewsProgress seen on five fronts for substantially improving treatment of epidermolysis bullosaJuly 27, 2023Rare DiseasesDermatology
Internal Medicine NewsIn new era of gene therapy, PCPs are ‘boots on the ground’July 19, 2023Rare DiseasesEndocrinology
Internal Medicine NewsEULAR systemic sclerosis recommendations now include immunosuppressantsJune 5, 2023DermatologyRheumatologyRare Diseases
